(Q54204246)

26 May 2018

title

Safety of the long-time monthly triple dose of a Gd-based contrast agent. (English)

1 reference

26 May 2018

1 reference

Francesco Sardanelli

1

0 references

Gianluigi Mancardi

object named as

Gianluigi Mancardi

series ordinal

2

0 references

Massimo Filippi

object named as

Massimo Filippi

series ordinal

3

0 references

language of work or name

English

0 references

publication date

26 March 2003

1 reference

26 May 2018

published in

European Radiology

1 reference

26 May 2018

volume

13 Suppl 6

1 reference

26 May 2018

page(s)

L243-4

1 reference

26 May 2018

Comparison of triple dose versus standard dose gadolinium-DTPA for detection of MRI enhancing lesions in patients with MS.

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00330-003-1830-Y

Safety and effectiveness of single- versus triple-dose gadodiamide injection- enhanced MR angiography of the abdomen: a phase III double-blind multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-003-1830-Y

Gadolinium-DTPA as X-ray contrast medium in clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-003-1830-Y

Gadolinium-containing contrast media for radiographic examinations: a position paper

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-003-1830-Y

Autologous hematopoietic stem cell transplantation suppresses Gd-enhanced MRI activity in MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00330-003-1830-Y

Gd-enhanced MR imaging of brain metastases: Contrast as a function of dose and lesion size

21 January 2018

1 reference

12 December 2020

A multi-centre longitudinal study comparing the sensitivity of monthly MRI after standard and triple dose gadolinium-DTPA for monitoring disease activity in multiple sclerosis. Implications for phase II clinical trials.

1 reference

12 December 2020

Comparison of the safety of standard and triple dose gadodiamide injection in MR imaging of the central nervous system. A double-blind study

1 reference

12 December 2020

Triple dose of gadolinium-DTPA increases the sensitivity of spinal cord MRI in detecting enhancing lesions in multiple sclerosis

1 reference

12 December 2020

MRI evaluation of "solitary" brain metastases with triple-dose gadoteridol: comparison with contrast-enhanced CT and conventional-dose gadopentetate dimeglumine MRI studies in the same patients

1 reference

12 December 2020

Safety of gadolinium contrast agent in hemodialysis patients

1 reference

12 December 2020

10.1007/S00330-003-1830-Y

Identifiers

DOI

1 reference

26 May 2018

1 reference

26 May 2018